8-K: Cingulate Inc. Granted Nasdaq Extension, Regains Board Compliance

Cingulate Inc. has been granted an extension to maintain its Nasdaq listing through May 13, 2024, after regaining compliance with board composition requirements.

Summary

• Cingulate Inc. received notification from the Nasdaq Hearings Panel on February 22, 2024, regarding its listing status.
• The company regained compliance with Nasdaq's board composition rules after appointing three independent board members on February 12, 2024.
• An exception was granted, allowing Cingulate to maintain its listing through May 13, 2024, despite not meeting the minimum stockholders' equity requirement of $2.5 million.
• This exception is conditional, requiring the company to promptly report any significant events that could impact its ability to meet the terms of the exception.
• The Nasdaq Hearings Panel reserves the right to reconsider the exception if circumstances change.
• Cingulate was previously notified of non-compliance with the minimum stockholders' equity rule on May 16, 2023, and received an extension until November 13, 2023, to regain compliance.
• The company also received a delisting notice on November 14, 2023, due to non-compliance with the minimum stockholders' equity rule.
• Additionally, the company was notified on December 26, 2023, of non-compliance with independent director and committee requirements due to board member resignations.
• Cingulate regained compliance with the minimum bid price requirement after a reverse stock split on November 30, 2023, and received notice of compliance on December 15, 2023.

Sentiment

Score: 4

Explanation: The document highlights significant challenges and risks related to Nasdaq listing compliance, despite some positive steps taken. The company is still at risk of delisting.

Positives

• Cingulate has successfully regained compliance with Nasdaq's board composition requirements.
• The company has been granted an extension to maintain its Nasdaq listing through May 13, 2024.
• Cingulate has addressed the minimum bid price non-compliance through a reverse stock split.

Negatives

• Cingulate is still not in compliance with the minimum stockholders' equity requirement of $2.5 million.
• The company has received multiple notices of non-compliance from Nasdaq.
• The company's listing is still at risk if it fails to meet the terms of the exception or other listing requirements.

Risks

• Failure to maintain compliance with Nasdaq's continued listing requirements could result in delisting.
• Delisting could negatively impact the price of the company's stock and warrants.
• Delisting could reduce the liquidity of the company's securities.
• Delisting could harm the company's ability to raise capital.
• The Nasdaq Hearings Panel can reconsider the exception at any time.
• There is no assurance that the company will maintain long-term compliance with the minimum stockholders' equity rule.

Future Outlook

Cingulate must maintain compliance with Nasdaq's continued listing requirements, including the minimum stockholders' equity rule, or risk delisting. The company must also promptly notify the Panel of any significant events that could impact its ability to meet the terms of the exception.

Management Comments

• There can be no assurance that we will be able to evidence the ability to maintain long term compliance with the Minimum Stockholders Equity Rule pursuant to the Exception, or that we will ultimately sustain compliance with all applicable requirements for continued listing on The Nasdaq Capital Market.

Industry Context

This announcement highlights the challenges faced by companies in maintaining compliance with Nasdaq listing requirements, particularly in the current economic climate. Many companies are facing similar issues with minimum equity and bid price requirements.

Comparison to Industry Standards

• Many small-cap and micro-cap companies struggle to maintain the minimum $2.5 million stockholders' equity required by Nasdaq, especially in volatile markets.
• The need for a reverse stock split to maintain the minimum bid price is a common occurrence for companies facing delisting threats, similar to other companies in the biotech and pharmaceutical sectors.
• The appointment of independent board members to meet Nasdaq requirements is a standard practice for companies seeking to maintain their listing.

Stakeholder Impact

• Shareholders face the risk of delisting, which could negatively impact the value of their investment.
• Employees may experience uncertainty due to the company's financial challenges and listing status.
• Customers and suppliers may lose confidence in the company if it is delisted.

Next Steps

• Cingulate must provide the Panel with prompt notification of any significant events that occur.
• Cingulate must evidence the ability to maintain long term compliance with the Minimum Stockholders Equity Rule.
• Cingulate must maintain compliance with all applicable requirements for continued listing on The Nasdaq Capital Market.

Key Dates

Keywords

Nasdaq, listing, compliance, delisting, stockholders' equity, board composition, minimum bid price, reverse stock split, extension, capital markets